Outlook Therapeutics Inc. (OTLK)
Market Closed
17 Jul, 20:00
$
1. 39
-0.07
-4.7945%
$
64.59M Market Cap
- P/E Ratio
- Div Yield
9.63M Volume
-0.23 Eps
$ 1.46
Previous Close 
Want to track OTLK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Outlook Therapeutics Inc. (OTLK) Statistics
Valuation metrics
Market Cap 64.59M
Enterprise value 76.62M
Trailing P/E (ttm) -1.02
Forward P/E -1.34
PEG ratio 0.01
Price/Sales (ttm) 171.65
Price/Book (mrq) -3.92
Enterprise Value/Revenue 230.01
Enterprise Value/EBITDA -1.23
Overview
Shares outstanding 64.56M
Float 67.73M
Shares short 3.69M
% Held by insiders 0.18%
% Held by institutions 0.08%
Average volume (10 days) 9.52M
Average volume (90 days) 18.41M
Price summary
52-Week low 0.16
52-Week high 3.39
Beta -0.08
50-Day moving average 1.33
200-Day moving average 0.44
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 14 Mar 2024
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -182.98%
Operating margin -181.83%
Operational effectiveness
Return on assets -2.78%
Return on equity 1.78%
Income Statement
Revenue (ttm) 205.7K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) 12.16%
Gross profit (ttm) -22.34M
EBITDA -58.82M
Net income to common (ttm) -102.86M
Diluted EPS (ttm) -0.74
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.68M
Total cash per share (mrq) 0.09
Total debt (mrq) 36.89M
Total Debt/Equity (mrq) -0.94
Current ratio (mrq) 0.54%
Book value per share (mrq) -0.35
Cash Flow
Cash flow statement -55.8M
Levered free cash flow (LFCF) -34.42M
